HemostOD appoints an International Scientific Advisory Board
HemostOD is proud to present the profiles our distinguished scientific advisors.
HemostOD receives a FIT Tech Growth loan
HemostOD received the support of the “Fondation pour l’Innovation Technologique” (FIT) in the form of a CHF 500’000 loan: the FIT Tech Growth. The FIT Tech programme supports Swiss startups in their development and to accelerate their commercialization. https://www.fondation-fit.ch/en/general/news/2024/hemostod-and-emissium-receive-support-from-fit
HemostOD partners with the biggest transfusion service in Switzerland
The Swiss preclinical biotech company HemostOD and Interregional Blood Transfusion SRC, the biggest Swiss blood transfusion services, are pleased to announce their partnership to collaborate on the in vitro production of platelets. The collaboration will empower the development from bioreactor to patients. In vitro production of blood cells (i.e. in bioreactor) has emerged during the […]
HemostOD enters EIT Health’s Gold Track Programme
HemostOD has been recognized as a promising healthcare company by a jury of experts. The team will now receive tailored support to grow the company.
Partnering with the Swiss Biotech Center
HemostOD partners with the Swiss Biotech Center to pre-industrialize its technology. Thanks to this new partnership HemostOD will benefit from solid expertise and state-of-the-art infrastructure in bioprocess engineering. Link to the press release
Tech Seed loan
HemostOD receives a loan of CHF 100’000 from the Foundation for Technological Innovation (FIT).
Seed Round
HemostOD raises CHF 1.7M in seed round financing.
Venture Kick II
HemostOD wins Venture Kick’s second stage of financial (CHF 40’000) and entrepreneurial support. Link to Venture Kick Programme
Venture Kick I
HemostOD receives the support of Venture Kick’s first stage (CHF 10’000). Link to Venture Kick Programme
